South Africa's Life Healthcare said on Wednesday half-year earnings could fall as much as 55 percent due to costs related to the disposal of its stake in India's Max Healthcare, impairments and other investments.

Anthem Inc's first-quarter profit beat Wall Street estimates on Wednesday as it reined in expenses, and the U.S. health insurer raised its earnings forecast for the year.

* Top-selling Tecfidera misses expecatations, Spinraza shines

Drugmaker Biogen Inc reported a 20 percent rise in first-quarter profit on Wednesday on higher sales of its muscle disease treatment Spinraza.

Thermo Fisher Scientific Inc on Wednesday raised its 2019 forecasts for adjusted profit and revenue on the back of its $1.7 billion deal to buy Brammer Bio, and beat the average analyst estimate for first-quarter profit.

South Africa's Life Healthcare said on Wednesday half-year earnings could fall as much as 55 percent due to costs related to the disposal of its stake in India's Max Healthcare, impairments and other investments.

Health insurer Anthem Inc reported an 18.2 percent rise in quarterly profit on Wednesday, as revenue from its commercial and government businesses rose.

* Says "business as usual" for migraine drug despite court case

President Donald Trump is expected to tout his fight against opioid abuse in remarks in Atlanta on Wednesday, a day after his administration brought its first related criminal charges against a major drug distributor and company executives.

Hundreds of drones will begin delivering life-saving vaccines, blood and medicines to patients in Ghana this week in the largest scheme of its kind, the global vaccine alliance GAVI said on Wednesday.